Docusate Sodium and Sennosides
NDC 35916-0453, Docusate Sodium and Sennosides, capsule, gelatin coated, from SOFTGEL HEALTHCARE PRIVATE LIMITED.
- Product NDC
- 35916-0453
- Status
- Listed
- Labeler
- SOFTGEL HEALTHCARE PRIVATE LIMITED
- Dosage form
- CAPSULE, GELATIN COATED
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M007
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/35916-0453 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SENNOSIDES8.6 mg/1
- DOCUSATE SODIUM50 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 35916-0453-1 | 35916045301 | 500 CAPSULE, GELATIN COATED in 1 BOTTLE (35916-0453-1) |
| 35916-0453-3 | 35916045303 | 2 POUCH in 1 BOX (35916-0453-3) / 3000 CAPSULE, GELATIN COATED in 1 POUCH |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 35916-0453 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/35916-0453 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 35916-0453. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.